Over the past couple of months, we have achieved significant regulatory milestones for RP1 in anti-PD-1 failed melanoma,” said Sushil Patel, ...

Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to ...

DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...

A judge issued a temporary restraining order against the Trump administration, ordering it to restore numerous webpages that ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Melissa Gilbert Says 'Little House On The Prairie' Reboot At Netflix "Will Do Things We Didn't Get To Do So Easily In '70s" ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...

Robert F. Kennedy Jr. transferred ownership of the trademark application in December and its abbreviation — MAHA — to an LLC ...

The Food and Drug Administration just raised its recall of Lay’s Classic Potato Chips to the highest risk level. On Dec. 16, Frito-Lay issued a recall for 6,344 (13-ounce) bags of Lay’s ...

Raymond James noted that the company’s initial 2025 EPS guidance was slightly better ... its position in key franchises. Also Read: FDA Approves Johnson & Johnson’s Treatment As First ...